"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...